Xu, Ya-Xiong
Xiong, Yu
Tian, Hong-qiang
Yang, Yan-hao
Tao, Rong-zhen
Li, Yun-Peng
Article History
Received: 4 July 2024
Accepted: 31 October 2024
First Online: 8 November 2024
Declarations
:
: The authors declare no competing interests.
: The studies involving humans were approved by the clinical research ethics committee of the Affiliated Jiangning Hospital of the Nanjing Medical University.The Chinese Clinical Trial Registry has accepted the protocol (ethics approval number: ChiCTR2200056752). The studies were conducted in accordance with the local legislation and institutional requirements. The patients/participants provided their written informed consent to participate in this study.